ArticleOncology2025

MUC17 Is a Potential New Prognostic Biomarker and Promotes Pancreatic Cancer Progression in Obstructive Jaundice.

Eleonóra Gál et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.